| Nome del prodotto |
grayanotossina III emi(acetato di etile)*addotto |
| Sinonimi |
Grayanotoxin III;Andromedol; BRN 2059374; Deacetilandromedotossina; Deacilasebotossina I;Grayanotoxane-3,5,6,10,14,16-hexol, (3-beta,6-beta,14R)-; NSC 323778; (3beta,6beta,14R)-grayanotoxane-3,5,6,10,14,16-esolo; 7,9a-metano-9aH-ciclopenta(b)eptalene-2,4,8,11,11a,12(1H)-esolo, dodecaidro-1,1,4,8-tetrametil-, (2S,3as,4R,4ar,7R,8R,9as,11R,11aR,12R)-; Grayanotoxane-3,5,6,10,14,16-hexol, (3beta,6beta,14R)- (9CI); grayanotoxane-3,5,6,10,14,16-esolo; (1beta,3alfa,5alfa,6alfa,8beta,9alfa,10alfa,13beta,14S)-grayanotoxane-3,5,6,10,14,16-esolo; (3beta,6beta)-grayanotoxane-3,5,6,10,14,16-esolo |
| Nome inglese |
grayanotoxin iii hemi(ethyl acetate)*adduct;Grayanotoxin III; Andromedol; BRN 2059374; Deacetylandromedotoxin; Deacylasebotoxin I; Grayanotoxane-3,5,6,10,14,16-hexol, (3-beta,6-beta,14R)-; NSC 323778; (3beta,6beta,14R)-Grayanotoxane-3,5,6,10,14,16-hexol; 7,9a-Methano-9aH-cyclopenta(b)heptalene-2,4,8,11,11a,12(1H)-hexol, dodecahydro-1,1,4,8-tetramethyl-, (2S,3as,4R,4ar,7R,8R,9as,11R,11aR,12R)-; Grayanotoxane-3,5,6,10,14,16-hexol, (3beta,6beta,14R)- (9CI); grayanotoxane-3,5,6,10,14,16-hexol; (1beta,3alpha,5alpha,6alpha,8beta,9alpha,10alpha,13beta,14S)-grayanotoxane-3,5,6,10,14,16-hexol; (3beta,6beta)-grayanotoxane-3,5,6,10,14,16-hexol |
| Formula molecolare |
C20H34O6 |
| Peso Molecolare |
370.4804 |
| InChI |
InChI=1/C20H34O6/c1-16(2)13(21)7-12-18(4,25)11-6-5-10-15(23)19(11,9-17(10,3)24)8-14(22)20(12,16)26/h10-15,21-26H,5-9H2,1-4H3/t10?,11-,12-,13-,14+,15?,17+,18+,19-,20-/m0/s1 |
| Numero CAS |
4678-45-9 |
| Struttura molecolare |
|
| Densità |
1.36g/cm3 |
| Punto di ebollizione |
552.6°C at 760 mmHg |
| Indice di rifrazione |
1.619 |
| Punto d'infiammabilità |
250.9°C |
| Pressione di vapore |
1.63E-14mmHg at 25°C |
| Simboli di pericolo |
|
| Codici di Rischio |
|
| Sicurezza Descrizione |
|
|
